NATHAN KOSCUK: Open Payments
NPI 1326809237 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,810 in 136 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,414 · 2025 $2,810
Food & beverage: $2,715Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $555 |
| ABBVIE INC. | 22 | $422 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $363 |
| Ardelyx, Inc. | 9 | $248 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $242 |
| Madrigal Pharmaceuticals | 7 | $172 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Aimmune Therapeutics, Inc. | 8 | $129 |
| Celltrion USA Inc. | 6 | $129 |
| Phathom Pharmaceuticals, Inc. | 4 | $119 |
Products named: TREMFYA, ENTYVIO, IBSRELA, XIFAXAN, DUPIXENT, RINVOQ, REZDIFFRA, ZENPEP.
Industry payments across PA — which companies pay providers there.
